key: cord-0256515-npb8ttes
authors: Brown, Susie L.; Bauer, Jonathan J.; Lee, Juhyung; Ntirandekura, Enatha; Stumhofer, Jason S.
title: IgM+ and IgM- memory B cells represent heterogeneous populations capable of producing class-switched antibodies and germinal center B cells upon re-challenge with P. yoelii
date: 2021-09-30
journal: bioRxiv
DOI: 10.1101/2021.03.04.433964
sha: 1ed98013a6e28415c43dc988a9055055f8073919
doc_id: 256515
cord_uid: npb8ttes

Memory B cells (MBCs) are essential for maintaining long-term humoral immunity to infectious organisms, including Plasmodium. MBCs are a heterogeneous population whose function can be dictated by isotype or expression of particular surface proteins. Here, aided by antigen-specific B-cell tetramers, MBC populations were evaluated to discern their phenotype and function in response to infection with a non-lethal strain of P. yoelii. Infection of mice with P. yoelii 17X resulted in the production of two predominant MBC populations: somatically hypermutated isotype-switched (IgM-) and IgM+ MBCs that co-expressed CD73 and CD80 that produced antigen-specific antibodies in response to secondary infection. Re-challenge experiments indicated that IgG-producing cells dominated the recall response over the induction of IgM-secreting cells, with both populations expanding with similar timing during the secondary response. Furthermore, using ZsGreen1 expression as a surrogate for activation-induced cytidine deaminase expression alongside CD73 and CD80 co-expression, ZsGreen1+CD73+CD80+IgM+ MBCs gave rise to class-switched IgG-producing plasmablasts that induced comparable titers of Ag-specific Abs as their IgM- counterparts after adoptive transfer and infection with P. yoelii. Moreover, ZsGreen1+CD73+CD80+ IgM+ and IgM- MBCs differentiated into B cells with a germinal center phenotype after adoptive transfer. A third population of B cells (ZsGreen1-CD73-CD80-IgM-) that emerges after infection responded poorly to reactivation in vitro and in vivo, indicating that these cells do not represent a population of MBCs. Together these data indicated that MBC function is not defined by immunoglobulin isotype, nor does co-expression of key surface markers limit the potential fate of MBCs after recall. Summary IgM+ and IgM- MBCs that co-express CD73 and CD80 can differentiate into plasmablasts and GC B cells after re-challenge with P. yoelii.

re-encounter. They can differentiate into antibody-secreting cells (ASCs) upon Ag recognition. 1 origin. 6,7 Nevertheless, interpreting these recent findings on the biology of MBCs has proved to 50 be complex. For instance, the ability of MBCs to re-enter the GC remains a point of 51 controversy, 8-10 as this event may be restricted to IgM + MBCs and depend on the presence of 52 persistent GCs. 3,11 Also, recent evidence indicates that a bottleneck event occurs that restricts the 53 ability of MBCs to re-enter the GC. 12 Conversely, others suggest that isotype-switched MBCs 54

can re-enter GCs after challenge. 13 In contrast, other evidence indicates that functionality is 55 defined based on the presence or absence of cell surface markers, such as CD80, PD-L2, and 56 CD73, rather than the isotype of the BCR. 2,14,15 These findings suggest functional heterogeneity 57 within the MBC pool. However, the contradicting results are likely the product of the models 58 utilized to evaluate MBC function and highlight the need for additional studies to assess MBC 59 heterogeneity on functional outcome, particularly in the context of infection-induced responses. 60

Studies in humans link Plasmodium-specific antibody (Ab) responses to protection from 61 clinical disease. [16] [17] [18] [19] [20] Additionally, experimental mouse models of malaria indicate that B cells 62 Furthermore, using a fluorescent ZsGreen1 protein as a surrogate for activation-induced 85 cytidine deaminase (AID) expression and CD73 + CD80 + co-expression, adoptive transfer of 86 CD73 + CD80 + ZsGreen1 + IgM + or IgM -MBCs into naïve mice followed by infection with P. 87 yoelii indicated that these MBC populations possess the ability to differentiate into plasmablasts 88 or GC B cells. In contrast, CD73 -CD80 -ZsGreen1 -IgM -B cells responded poorly to reactivation 89

in vitro compared to their ZsGreen1 + counterparts, and they did not display the ability to 90 differentiate into plasmablasts or GC B cells after adoptive transfer, indicating that they are not a 91 functional MBC population. Collectively, these studies suggest that somatically hypermutated P. Negative fractions were combined and stained to identify populations of MBCs. Live, single-cell 189 CD19 + B220 + CD38 + GL7 -MBCs were sorted based on the following parameters: IgM + 190 (CD73 + CD80 + ZsGreen1 + IgG -IgD +/-), or IgM -(CD73 + CD80 + ZsGreen1 + IgM -IgDor CD73 -CD80 -191

ZsGreen1 -IgM -IgD +/-) using a BD Biosciences FACSAria. FACS sorted cells were rested in 192 cRPMI at 37°C for at least 30 minutes before prepping the cells for transfer. Cells were washed 193 two times in sterile 1 ´ PBS and then resuspended in sterile 1 ´ PBS. Cells were loaded into a 1 194 ml syringe with a 30-gauge needle. Approximately 4-8 ´ 10 4 CD73 + CD80 + ZsGreen1 + IgM + , 195 Following activation with 35% EtOH, ELISpot plates (Millipore cat # MAHAS4510) were coated 214 overnight at 4°C with 2.5 µg/ml of P. yoelii recombinant MSP-142 or AMA-1 protein in PBS. The 215

following day, the plates were blocked for 30 minutes at room temperature with cRPMI. 216

Afterward, 10 5 splenocytes were plated and incubated overnight at 37°C in cRPMI. Next, plates 217

were washed with PBS and then blocked with 5% FBS in PBS for 1 h at room temperature. 218

Secondary IgM-AP (SouthernBiotech cat # 1020-04) or IgG-AP (SouthernBiotech cat # 1030-04) 219

conjugated Abs were then incubated for 1 hour at 37°C in 5% FBS in PBS. Finally, an ELISpot 220 developing reagent (consisting of BCIP and NBT; Sigma Millipore) was used to visualize spots; 221 subsequently, an AID ELISpot reader system (Autoimmun Diagnostika, Strassberg, Germany) 222 was utilized to calculate the number of ASCs. 223

For the MBC ELISpot assays, sorted populations of MBCs (CD73 + CD80 + ZsGreen1 + IgG -224

IgD +/-, CD73 -CD80 -ZsGreen1 -IgG -IgD +/-, CD73 + CD80 + ZsGreen1 + IgM -IgD -, or CD73 -CD80 -225

ZsGreen1 -IgM -IgD +/-) were plated at a concentration of 5,000/well in 96-well round-bottom plates. 226

MBCs were restimulated in the presence of the TLR7 agonist R848 (1 µg/ml; Invivogen, San 227 Diego, CA) and human IL-2 (10 ng/ml; Peprotech, Rocky Hill, NJ) with or without splenic feeder 228 cells depleted of B cells (50,000/well). Splenic feeder cells incubated with R848 and human IL-2 229 and MBCs incubated without restimulation or added splenic feeder cells served as controls. Cells 230 were incubated in vitro for three days at 37°C. After three days, the cells were transferred to 231

ELISpot plates pre-coated with 2.5 µg/ml of P. yoelii recombinant MSP-142 and AMA-1 or 10 232 µg/ml anti-mouse Kappa (Southern Biotech). Cells were incubated for 16-24 h at 37°C. Spots were 233 visualized as described above. Results 239

To phenotypically define MBC subsets after infection, C57BL/6 wild-type (WT) mice were 242 infected with a non-lethal strain (17X) of P. yoelii. Periodically over the course of the infection 243 and after clearance (Supplemental Fig. 1A ), spleens were harvested and stained for several 244 phenotypic markers associated with MBCs, 14,15,47,48 including proteins that regulate T cell 245 activity (CD80, PD-L2), enzymes involved in the generation of adenosine from ATP (CD73, 246 CD39), the chemokine receptor CCR6, and the receptor for leukemia inhibitory factor (LIFR). 247

While the specific role of these proteins on MBC function is largely unknown, a loss of these 248 proteins through germline deletion or inhibition of ligand-receptor interactions can negatively 249 impact the immune system. 49-56 250

As several effector B cell populations emerge after infection, we used a gating strategy to 251 distinguish between CD138 + CD38 lo/plasmablasts (PBs), CD38 -GL-7 + germinal center (GC) B 252 cells, CD38 + GL-7 + multipotent precursors, 6 and expanding CD38 + GL-7 -MBCs in the spleen. 253

The CD38 + GL-7 + multipotent precursors represent a transitional stage in B cell differentiation 254 that precedes the formation of GC B cells and MBCs and possesses the ability to differentiate 255 into these populations. 6 Within the CD138 -CD38 + GL-7population B cells were further 256 subdivided into IgM + and IgMgroups (Supplemental Figure 1B) . It is important to recognize 257 that a large proportion of the CD38 + GL-7 -IgM + B cells are naïve B cells, as they are 258 indistinguishable from MBCs based on this phenotype. Subsequent analysis of the MBC 259 associated markers CD73 and CD80 revealed the segregation of IgM + and IgM -MBCs into two 260 predominant populations: CD73 + CD80 + and CD73 -CD80 - (Fig. 1A) . This CD73 and CD80 261 expression pattern resembled that seen for 4-hydroxy-3-nitrophenylacetyl (NP)-specific MBCs 262 after immunization with NP-chicken g-globulin (NP-CGG) 15 or infection with P. chabaudi. 41 263

Shortly after infection, expansion in the IgM + CD73 + CD80 + population occurred, followed by a 264 decline. Then a second expansion that peaked at day 70 post-infection (p.i.) was observed. 265

Similarly, IgM -CD73 + CD80 + MBC numbers peaked at day 70. While IgM -CD73 + CD80 + MBC 266 numbers declined after day 70, the IgM + CD73 + CD80 + MBCs were steadily maintained through 267 day 350 p.i. (Fig. 1B) . However, the decline in IgM -CD73 + CD80 + cell numbers was not as steep 268 as that seen for the IgM -CD73 -CD80cells, which saw a >30-fold reduction in numbers from 269 day 70 to day 350. Although, the overall number of IgM -CD73 -CD80 -MBCs was higher in the 270 spleen almost a year after infection than the IgM -CD73 + CD80 + MBCs (Fig. 1B) . The IgM + CD73 -271 CD80population encompasses MBCs and naïve B cells; it is not surprising that their numbers 272 remained steady past day 70 p.i. 273

Using the expression of CD80 and CD73 to define MBC populations, the expression of the 274 other aforementioned markers associated with MBCs was examined. The majority of the CD73 -275 CD80cells, regardless of their isotype, did not express PD-L2. Also, PD-L2 expression was not 276 uniform amongst the CD73 + CD80 + cells; however, a higher frequency of IgM -CD73 + CD80 + 277

MBCs expressed PD-L2 compared to IgM + CD73 + CD80 + MBCs (Fig. 1C ). Regarding the 278 expansion of the CD73 + CD80 + PD-L2 + MBCs, IgM + , and IgMpopulations displayed an early 279 peak in expansion with the IgM + cells peaking sooner (Fig. 1D) . However, these peaks were 280 followed by a contraction event in both populations through day 42 p.i., before each population 281 expanded a second time. After this second peak plateaued at day 70 for the IgMcells, they 282 contracted over time while the IgM + cell numbers remained steady. 283

Since CD39 assists CD73 in breaking down ATP to adenosine, 57 it was not surprising that 284 most CD73 expressing MBCs (IgM + and IgM -) co-expressed CD39. Also, a high frequency 285 (>50%) of the CD73 -MBCs (IgM + and IgM -) expressed CD39 (Fig. 1E) . The IgM + 286 CD73 + CD39 + cells peaked early after infection, then reduced between days 21 and 35 p.i. but 287 thereafter, the numbers remained steady over time (Fig. 1F ). In contrast, the IgM -CD73 + CD39 + 288 cells plateaued at day 28 p.i. before declining in numbers after day 70. 289

The chemokine receptor CCR6 is associated with MBC precursors found within the light 290 zone of the GC, 58 and CD38 + GL-7 + multipotent precursors express CCR6. 6 Early on, after the 291 infection, the per-cell expression of CCR6 was the highest for the CD38 + GL-7 + multipotent 292 precursors (Fig. 1G ). As the infection progressed, the fluorescent intensity of CCR6 decreased on 293 this population, correlating with the decline in this population (data not shown). Within the MBC 294 pool, a small proportion of IgM + and IgM -MBCs showed expression of CCR6, with a higher 295 expression on the IgM + cells, which includes naïve B cells. Still, most CD73 + MBCs do not 296 express this chemokine receptor, possibly suggesting that MBCs lose expression of this receptor 297 with maturation or only a subset of them express it (Fig. 1G,H) . Similarly, the expression of 298 CCR6 was low amongst GC B cells upon their initial appearance but increased slightly over time 299 (Fig. 1G ). Signaling through the LIFR is linked to the self-renewal and survival of murine 300 hematopoietic stem cells, 54,59 and it is upregulated and responsive to LIF stimulation on MBCs. 47 301

Here, a sizable proportion of IgM + and IgM -CD73 + CD80 + MBCs express the LIFR while very 302 few CD73 -CD80 -MBCs express this receptor after P. yoelii infection (Fig. 1I) . Expression of CD73 by B cells is thought to be associated with the expression of activation-304 induced cytidine deaminase (AID) through either a GC-dependent or -independent manner, as 305 the majority of CD73 + MBCs have a high rate of somatic mutations in their BCR. 6,14,60 To 306 confirm that CD73 and CD80 co-expression coincides with AID expression, we crossed a mouse 307 in which cre recombinase (aicda cre/+ ) replaces the endogenous AID protein with a mouse 308 expressing the R26 ZsGreen1 allele (Ai6). Thus, cre-mediated recombination in the subsequent 309 offspring leads to permanent ZsGreen1 fluorescent protein marking upon expression of the Aicda 310 locus (aicda cre Ai6 mice). 61,62 Regardless of isotype, the CD73 + CD80 + MBCs favored expression 311 of the ZsGreen1 protein, indicating they turned on AID transcription, whereas only a small 312 fraction of IgM + or IgM -CD73 -CD80 -MBCs expressed ZsGreen1 (Fig. 2) . Thus, while CD73 313 and CD80 co-expression did largely correlate with AID expression, it was not absolute. 314

Furthermore, while only a small proportion of IgM + and IgM -CD73 -CD80 -B cells expressed 315

ZsGreen1, sizable numbers of these cells were present in the spleen, particularly for those that 316 expressed IgM, though the numbers for both populations were reduced on average compared to 317 the CD73 + CD80 + cells (Fig. 2C) . 318

Another layer of diversity in MBCs was recently described in the mouse model of P. 319 chabaudi infection. A proportion of the IgM + MBCs also expresses high amounts of IgD on their 320

surface. 41 Indeed, here, a sizable proportion of the IgM + CD73 + CD80 + B cells were IgD + , 321

whereas only a small proportion of the IgM -CD73 + CD80 + were IgD + (Supplemental Fig. 1C) . MBCs. Lastly, we noted that the expression of the B-cell co-receptor component CD19 was 329 significantly higher on IgM + and IgM -B cells that co-expressed CD73 and CD80 compared to 330 those that did not express these cell surface markers (Supplemental Fig. 1C) . 331

Together these data indicate that based on differences in the expression of several cell surface 332 proteins, MBCs represent a population of cells, at least phenotypically, with multiple layers of 333 diversity. However, the layers of diversity seem less dependent on the isotype of the BCR but 334 rather dependent on the experiences of the B cell itself within the environment that forms after P. protein-1 (MSP-1) from P. yoelii was generated. This reagent was subsequently used to label Ag-343 specific B cells ex vivo, followed by magnetic bead-based enrichment of the labeled cells. As 344 components of the tetramer itself, such as PE, can be bound by B cells, splenocytes were first 345 stained with a decoy reagent to exclude them before incubation with the MSP-1 PE tetramer. 46 346

Anti-PE-specific microbeads were then used to enrich the tetramer and decoy-specific B cells, 347

which were subsequently labeled with Abs for analysis and quantitation by flow cytometry. After 348 excluding dead cells, doublets, and non-B cells, B cell populations were identified and gated 349 based on B220 and CD138 expression. Decoy -MSP-1 + B cells were identifiable within this 350 population before and after P. yoelii infection (Fig. 3A) . Tracking MSP-1-specific B cells over 351

one year after infection indicated that MSP-1-specific B cells rapidly expanded and peaked in 352 cell numbers in the spleen shortly after infection and subsequently contracted by day 35. 353

Thereafter a second but smaller expansion in cell numbers occurred and peaked by day 70 p.i. 354 before contracting again by 100 days p.i. Hereafter the MSP-1-specific B cell numbers remained 355 consistent over one year p.i., but the numbers were higher than those seen in naïve mice (Fig.  356   3B) . 357

To corroborate our results with the MSP-1 tetramer, a similar set of experiments was 358 performed using a B cell tetramer composed of another blood-stage Ag, apical merozoite 359 antigen-1 (AMA-1) (Supplemental Fig. 2A ,B). Rather than peaking at day 7 p.i. as the MSP-1 + B 360 cells, AMA-1-specific B cells continued to expand in number throughout the infection, reaching 361 their peak at day 28. Following a contraction phase, a second smaller wave of expansion 362 occurred at day 70 before slowly contracting over time, a pattern that resembled that for the 363 specific CD38 + GL-7 + precursor B cells 6 were observed at days 7 and 12 after infection but were 368 not maintained beyond this time (Fig.3C , data not shown). MSP-1-specific plasmablasts peaked 369 in cell numbers by day 7 p.i. and contracted quickly by day 12 p.i. (Fig. 3D ). By day 7, a 370 transition from IgM + to class-switched MSP-1-specific plasmablasts was evident (Fig. 3E,F) , 371 likewise for AMA-1-specific plasmablasts (Supplemental Fig. 2C ,D). By day 12 p.i., the class-372 switched plasmablasts dominated the response (Fig. 3E,F) . Whereas a distinct second wave of 373 plasmablast formation started at 100 days after P. chabaudi infection and was visible out to 265 374 days p.i., 41 this degree of expansion was not apparent after P. yoelii infection (Fig. 3C, D) . MSP-375 1-specific GC B cells peaked at day 28 p.i. and were still detectable at 100 days p.i., but by day 376 168, these cells were no longer prevalent. CD38 + GL-7 -B cell numbers expanded at day 7 p.i. but 377 contracted at day 12. Then this population went through another small expansion and contraction 378 between day 28 and 35 p.i. before a large expansion took place after this time resulting in peak 379 numbers by day 70 p.i. Afterward, this population contracted before leveling out by 24 weeks p.i. 380 at day 5 p.c., though more IgMplasmablasts were prevalent at this time (Fig. 5A,D) . By day 9 455 p.c., the MSP-1-specific IgMplasmablasts dominated the response, though expansion was still 456 occurring amongst the Ag-specific IgM + plasmablasts. The MSP-1 + CD38 + GL-7 -B cells, 457 encompassing naïve and MBCs, and the MSP-1 + GC B cells also exhibited significant expansion 458 by days 5 and 9 p.c. respectfully (Fig. 5C) . 459

There was little to no change in MSP-1-specific IgM titers in the serum after re-challenge 460 (Fig. 5E ). In contrast, the MSP-1-specific IgG titers significantly increased by day 5 p.c., and 461 they remained significantly elevated at day 9 (Fig. 5E ). By ELISpot assay, there was only a 462 minimal increase in MSP-1-specific IgM-secreting cells in some mice at day 5 p.c. (Fig. 5F) , 463 mirroring the flow cytometry results (Fig. 5D ), but no further increase in numbers occurred at 464 day 9 p.c. Alternatively, primary infected mice showed a significant expansion in MSP-1-465 specific IgM-secreting cells at day 9. In contrast, the MSP-1-specific IgG-secreting cells showed 466 a significant expansion by day 5 p.c., and they remained elevated at day 9 (Fig. 5F ), like the flow 467 cytometry results (Fig. 5D) . Furthermore, MSP-1-specific ASCs were not detectable in the 468 spleen of mice with a primary P. yoelii infection until day 9 p.i. Their numbers were significantly 469 lower than those observed in the re-challenged mice. Overall, these data indicate that the MBC 470 response dominates the humoral response during secondary infection with P. yoelii. Together 471 these results suggest that Ag-specific MBCs generated during primary infection with P. yoelii 472 can differentiate into ASCs during secondary infection. Moreover, the IgG-producing ASCs 473 dominate the secondary response to P. yoelii with only a marginal input by IgM-producing 474

ASCs, which differs from the P. chabaudi re-challenge model findings. 41 In comparison, we 475 observed an expansion in B cells with a GC phenotype by day 9 p.c. However, it is unclear if 476

MBCs are responsible for this increase. The reduced expansion in Ag-specific IgM-secreting cells shortly after re-challenge indicates 481 that the IgM + MBCs may be non-responsive, possibly due to the high titers of MSP-1-specific 482

Abs still present in the serum before re-challenge, or they have the capacity to class switch and 483 become IgG-secreting cells after reactivation. A third possibility is that they preferentially 484 proceed to the GC. To explore these possibilities, we used an adoptive transfer approach. Using 485 P. yoelii infected aicda cre Ai6 reporter mice, IgM + and IgM -MBC populations expressing CD73, 486 CD80, and the ZsGreen1 protein were sorted and adoptively transferred into naïve congenic mice 487 that were subsequently infected with P. yoelii (Fig. 6A, Supplemental Fig. 4A,B) . The functional 488 capacity of the MBCs was evaluated 5, 8, and 28 days after infection. 489

The vast majority of the recovered donor cells at the early time points after infection 490 displayed a CD38 lo/-CD138 + phenotype indicative of plasmablasts (Fig. 6B,C) , signifying that 491 the transferred cells could differentiate into ASCs upon reactivation. Furthermore, while a 492

proportion of the donor IgM + MBCs differentiated into plasmablasts that expressed IgM, they 493 began downregulating IgM expression as early as day 5 p.i., and by day 8 p.i. they were 494

primarily IgM - (Fig. 6B,D) , suggesting their ability to undergo class switch recombination. This 495 was the case as congenic mice that received IgM + MBCs had detectable Ag-specific IgG in their 496 serum by day 8 compared to congenic mice that did not receive a donor cell transfer (Fig. 6E) . 497

Thus, IgM + and IgM -MBCs primarily differentiate into ASCs, with the IgM + MBCs undergoing 498 class switch recombination upon reactivation. 499

Transferred donor cells were still identifiable at day 28 p.i. (Fig. 6F) . These donor cells 500 primarily displayed a GC B cell phenotype (CD38 -GL-7 + ) at this time (Fig. 6F,G) , indicating that 501

IgM + and IgM -MBCs possess the ability to differentiate into GC B cells. Furthermore, Ag-502 specific MSP-1 + B cells were found amongst donor-derived GC B cells from each transferred 503 MBC population (Supplemental Fig. 4C,D) . Ag-specific IgG is readily detectable in the serum of 504 congenic mice that did not receive donor MBCs at day 28 (Supplemental Fig. 4E) . Therefore, the 505 impact of the transferred IgM + and IgM -MBCs on Ab production was not distinguishable from 506 the endogenous Ab response at this time. Overall, the transferred CD73 + CD80 + ZsGreen1 + IgM + 507 and IgM -MBCs displayed a similar function upon recall, differentiating into ASCs early after 508 reactivation and eventually progressing to a phenotype associated with GC B cell differentiation. 509 510 IgM -CD73 -CD80 -MBCs are non-responsive to reactivation 511

While the above studies confirmed the function of the IgM + and IgM -CD73 + CD80 + MBCs, they 512 did not address the function of the IgM -CD73 -CD80 -B cells, the other potential MBC 513 population identified in mice after P. yoelii infection (Fig. 1) . To address the role of these B cells 514

in a recall response, we attempted a similar approach, as shown in Figure 6 . Instead, we sorted 515 numbers recovered from the no transfer control group was isolated from the recipients of the 528 (Fig. 7B,C) . Similar results were observed at day 28, 529 as the number of recovered IgM -CD73 -CD80 -ZsGreen1donor B cells matched the background 530 amounts detected in the no transfer controls, and no ZsGreen1 + cells were recovered from these 531 mice (Fig. 7D-F) . 532

The significantly reduced yields seen for the cells derived from the IgM -CD73 -CD80 -533

ZsGreen1 -B cells may indicate that these cells have a reduced fitness upon transfer into a naive 534 host, possibly due to competition with naïve B cells for a survival signal. Therefore, as a separate 535 approach to evaluate their function, IgM -CD73 -CD80 -ZsGreen1 -B cells, naïve, and IgM + and 536

IgM -CD73 + CD80 + ZsGreen1 + B cells were sorted from aicda cre Ai6 reporter mice that recovered 537 from a P. yoelii infection and restimulated in vitro. The IgM + CD73 + CD80 + ZsGreen1 + B cells 538 and naïve B cells could differentiate into IgM-producing ASCs, and some of the secreted IgM 539 was Ag-specific (Fig. 8A,B) . As seen in vivo, a proportion of the IgM + CD73 + CD80 + ZsGreen1 + 540 B cells could undergo class switch recombination after reactivation and differentiate into IgG-541

producing ASCs with some producing Ag-specific IgG (Fig. 8C,D) . In contrast, the ability of 542 naïve B cells to undergo class switch recombination and make IgG + ASCs during this stimulation 543 period was reduced compared to the IgM + CD73 + CD80 + ZsGreen1 + MBCs. As expected, the 544 ability of the IgM -CD73 + CD80 + ZsGreen1 + MBCs to differentiate into IgG-producing ASCs was 545 superior to the other B cell populations tested (Fig. 8C,D) . yoelii mirrors the results of secondary immunization with PE, which the authors attributed to the 573 high serum quantities of anti-PE IgG circulating in these mice before re-exposure to PE. 4 Similar 574 to our findings here, the adoptive transfer of PE-specific IgM + MBCs into naïve mice that were 575 subsequently immunized with PE showed that these cells could recognize and respond to PE in 576 an environment lacking circulating anti-PE Abs giving rise to IgM -ASCs and GC B cells. 4 577

Hence, we speculate that the ability of IgM + MBCs to expand in response to secondary infection 578 with P. chabaudi and not P. yoelii is due to differences in Ag-specific Ab quantity and/or quality 579 in these mice at the time of re-infection. An idea supported by the differences in P. yoelii and P. 580 chabaudi to establish secondary infections with blood parasitemia only detectable for the latter. 581 P. chabaudi establishes a persistent infection after re-challenge, just as it did after primary 582 infection but at a lower level of parasitemia. 63 583

Thus, the Abs generated in response to primary infection with P. yoelii are more effective 584 at preventing re-establishment of infection than those produced in response to P. chabaudi 585 infection. Consequently, we speculate that critical epitopes recognized by the BCR of IgM + 586

MBCs and naïve B cells are preferentially bound by affinity-matured circulating Ag-specific Abs 587 or high-affinity BCRs associated with IgM -MBCs after re-infection with P. yoelii. In contrast, 588

Ag is readily available for binding and reactivating IgM + MBCs during secondary infection with 589 P. chabaudi. The difference in the effectiveness of the Abs can be attributed to any number of 590 factors, including increased titers and affinity of the Abs and differences in the production of Abs 591 that target specific proteins essential for RBC binding and entry. 592 Importantly, our in vitro results indicate that the IgM + MBCs can give rise to Ag-specific 593

IgM-secreting plasmablasts, meaning that these MBCs can respond to restimulation. However, in 594 vivo, they favored differentiation into IgM -ASCs even without circulating Ag-specific Abs. historical antimalarial responses than plasma antibodies in no-longer exposed children. Day 90 

Intrinsic properties of human and murine 713 memory B cells

CD80 and PD-L2 define functionally 715 distinct memory B cell subsets that are independent of antibody isotype

Multiple layers of B cell memory with different effector 718 functions

Different B Cell Populations Mediate Early and Late 720 Memory During an Endogenous Immune Response

Memory B cells and plasma cells: The differentiative continuum 722 of humoral immunity

A germinal center-independent pathway generates 724 unswitched memory B cells early in the primary response

T-independent type II immune responses generate 726 memory B cells

Do Memory B Cells Form Secondary Germinal Centers?

Do Memory B Cells Form Secondary Germinal Centers?

Do Memory B Cells Form 732 Secondary Germinal Centers?

Multiple players in mouse B cell memory

Class-switched memory B cells 738 remodel BCRs within secondary germinal centers

New markers for murine memory B cells that 740 define mutated and unmutated subsets

Cutting Edge: Hierarchy of Maturity of 742

Serum IgG3 to the Plasmodium falciparum 744 merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria

The Passive Transfer of Human Malarial Immunity

Gamma-globulin and acquired immunity to human 749 malaria

Naturally acquired cellular and humoral immune 751 responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are 752 associated with reduced malaria morbidity

Allele-specific antibodies to Plasmodium 754 falciparum merozoite surface protein-2 and protection against clinical malaria

Gene-targeted mice lacking B cells are unable to 757 eliminate a blood stage malaria infection

Immunity to Plasmodium chabaudi adami in the B-cell-deficient 759 mouse

Immunity to Plasmodium Berghei yoelii in mice. I. 761 The course of infection in T cell and B cell deficient mice

A role for B cells in the development of T cell helper 764 function in a malaria infection in mice

CD4+ T cells and B cells are necessary for the transfer of protective 766 immunity to Plasmodium chabaudi chabaudi

Young Lives Lost as B Cells Falter: What We Are 768 Learning About Antibody Responses in Malaria

Development of B Cell Memory in Malaria

Does malaria suffer from lack of memory?

Plasmodium falciparum-specific IgM B cells dominate in 872 children, expand with malaria, and produce functional IgM

Multimeric antibodies from antigen-specific 874 human IgM+ memory B cells restrict Plasmodium parasites

B cell analysis in SARS-CoV-2 versus malaria: 876 Increased frequencies of plasmablasts and atypical memory B cells in COVID-19

CD73-Generated Adenosine Restricts Lymphocyte 879 Migration into Draining Lymph Nodes

Down-regulation of CD73 on B cells of patients with 881 viremic HIV correlates with B cell activation and disease progression

Each data point on the 1092 graphs represents an individual mouse, and the error bars denote the mean ± S.E.M. Data are 1093 representative of two independent experiments with 3-5 mice

ANOVA with a post hoc Holm-Sidak's multiple comparisons test, n.s., not significant

ELISA from day 28 infected mice determined serum IgG titers specific for MSP-1 and AMA-1

showing the gating strategy to identify CD45.2 + ZsGreen1 + donor cells (left). Recovered donor 1088 cells were analyzed for their ability to differentiate into CD38 -GL-7 + GC B cells or retain their 1089 CD38 + GL-7 -MBC phenotype (middle). Donor cells that displayed a GC phenotype were 1090 subsequently analyzed to determine their ability to bind MSP-1 (right). (D) Frequency of GC B